About Vakaramoko "karam" Diaby
Dr. Diaby is currently the Track Director, Applied PharmacoEconomics for the UF Online Masters and an Assistant Professor of Pharmaceutical Outcomes and Policy, College of Pharmacy. He is also affiliated with the Cancer Population Science group – UF Cancer Center. As the Track Director of the Applied Pharmacoeconomics Track, he manages a team of instructors and is the Track content expert and its development and growth. He also represents the Track at conferences and events. As an Assistant Professor, he is responsible for teaching applied pharmacoeconomics in the Pharm D, residential and online program in Pharmaceutical Outcomes and Policy. Dr. Diaby has published over 50 peer-reviewed publications, including two book chapters. Dr. Diaby was the PI on a pilot project grant from the NIH/NIMHD, a Mitacs grant (Canada), and currently serves as a co-investigator on an NIH/NHGRI grant. He is the PI on a Nicklaus Children’s Hospital foundation pharmacogenomics grant and a Co-PI on an industry (Merck) contract. Dr. Diaby serves as a health economist on an HIV Telemedicine grant sponsored by the CDC. He completed a sub-award from a U54 center grant (U54OH011230) to study the impact of heat-related illness on the gross domestic product, agricultural and health sectors of the Southeastern and Coastal Center for Agricultural Health and Safety (SCCAHS)’ catchment area. He has been contributing service to the College of Pharmacy by sitting on the curriculum and faculty governance committees. He is a grant peer-reviewer for three international agencies (UK, New Zealand, and The Netherlands) and a peer-reviewer for several academic journals. Dr. Diaby was an academic editor for the journal PLOS ONE and currently serves on the editorial board of Pharmacoeconomics-Open. He has prior consulting experience with Pharma (e.g. Pfizer, Amgen in Canada; Merck in the US) and the Ontario government (Canada) and serves as a subject matter expert on several projects.
Clinical Research AssociateSup Sante Paris – France
Health economics; Pharmacoeconomics; Comparative effectiveness research; Health disparities; Multi-Criteria Decision Analysis (MCDA); Policy evaluations
- Breast Cancers
- Health disparities and vulnerable populations
- Women’s Health
The strategic planning workshop will help NHGRI establish a “2020 vision for genomics” and culminate in the publication of a new NHGRI strategic plan.
The study, partially funded by a UF College of Pharmacy PROSPER award, was published in Pharmacoeconomics Open.
Diaby’s team used a decision analytic model to simulate and compare the cost and effectiveness associated with treatment strategies.
Diaby will assist in a peer-review of research applications to improve pharmaceutical outcomes.